The pharmaceutical company will distribute BRL 0.26304 per common share by the end of 2027.
Brazilian pharmaceutical company Hypera Pharma approved the distribution of BRL 185.2 million in interest on equity, according to a corporate filing published on Wednesday, September 23, 2026.
The gross payout corresponds to BRL 0.26304 per common share. The distribution remains subject to withholding income tax at the source, except for shareholders proven to be immune or exempt.
Shareholders holding positions at the close of trading on September 28, 2026, will be entitled to receive the proceeds. The shares will trade ex-interest on equity starting on September 29, 2026.
The company stated that payment will occur by the end of the 2027 fiscal year on a date still to be scheduled. Hypera will not apply monetary adjustments to the declared amount between the announcement date and the actual payment date.
Newsletter
Markets in your inbox, weekly
Latin America-focused analysis, investment themes and the week in finance.
Keep reading